Clinical Trial Update: Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Interleukin-2 in children with stage IV neuroblastoma who have received induction therapy and peripheral stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: St. Anna Kinderkrebsforschung | Conditions: Neuroblastoma | Phase 2 | Status: UNKNOWN